Journals / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 6

Investigation of the protective effect of erdosteine against cyclosporine-inducedinjury in rat liver with histological and biochemical methods

Pages
1390–1395
Publication Date
2015-12-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Erdosteine could attenuate cyclosporine-induced liver injury.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: In the present study, the protective effect of erdosteine against cyclosporine-induced injury in rat liver was investigated with histological and biochemical methods.
📊
Key Findings & Data:Materials and methods: Thirty-two Wistar albino male rats were randomly divided into 4 groups: control (n = 8), cyclosporine (n = 8, 20 mg kg-1 day-1 i.p.), cyclosporine + erdosteine (n = 8, erdosteine 12 mg kg-1 day-1 orally), and erdosteine (n = 8).
💡
Conclusion & Impact:Conclusion: Erdosteine could attenuate cyclosporine-induced liver injury.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cyclosporine · erdosteine · antioxidant system

Abstract

Background/aim: In the present study, the protective effect of erdosteine against cyclosporine-induced injury in rat liver was investigated with histological and biochemical methods. Materials and methods: Thirty-two Wistar albino male rats were randomly divided into 4 groups: control (n = 8), cyclosporine (n = 8, 20 mg kg-1 day-1 i.p.), cyclosporine + erdosteine (n = 8, erdosteine 12 mg kg-1 day-1 orally), and erdosteine (n = 8). At the end of day 12, liver tissues were removed for histological and biochemical analysis. After liver tissues were fixed in 10% buffered neutral formalin, routine histological processes were applied and tissue sections were stained with hematoxylin and eosin, periodic acid-Schiff, and elastic fiber stain methods. One hundred lobules of liver were examined for each group and evaluated statistically. The levels of malondialdehyde and glutathione peroxidase, as well as the activities of superoxide dismutase, were determined. Results: The cyclosporine group showed significant histopathological changes compared to the control. In the cyclosporine + erdosteine group, histopathological changes of hepatic damage were markedly reduced. Histological findings were supported by biochemical results. Conclusion: Erdosteine could attenuate cyclosporine-induced liver injury.

Özet

Background/aim: In the present study, the protective effect of erdosteine against cyclosporine-induced injury in rat liver was investigated with histological and biochemical methods. Materials and methods: Thirty-two Wistar albino male rats were randomly divided into 4 groups: control (n = 8), cyclosporine (n = 8, 20 mg kg-1 day-1 i.p.), cyclosporine + erdosteine (n = 8, erdosteine 12 mg kg-1 day-1 orally), and erdosteine (n = 8). At the end of day 12, liver tissues were removed for histological and biochemical analysis. After liver tissues were fixed in 10% buffered neutral formalin, routine histological processes were applied and tissue sections were stained with hematoxylin and eosin, periodic acid-Schiff, and elastic fiber stain methods. One hundred lobules of liver were examined for each group and evaluated statistically. The levels of malondialdehyde and glutathione peroxidase, as well as the activities of superoxide dismutase, were determined. Results: The cyclosporine group showed significant histopathological changes compared to the control. In the cyclosporine + erdosteine group, histopathological changes of hepatic damage were markedly reduced. Histological findings were supported by biochemical results. Conclusion: Erdosteine could attenuate cyclosporine-induced liver injury.

🔖

Cite This Article

NACAR, A., KARABOĞA, İ., OKUYAN, H. M., SEFİL, N. K., NACAR, E., MOTOR, S., AKKÜÇÜK, S., ÖZKAN, O. V. (2015). Investigation of the protective effect of erdosteine against cyclosporine-inducedinjury in rat liver with histological and biochemical methods. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 6, 1390–1395. https://ajindex.com/articles/113761

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Grub S, Pershon E, Trommer WE, Wolf A. Mechanism of cyclosporine A-induced apoptosis in rat hepatocyte primary cultures. Toxicol Appl Pharm 2000; 163: 209–220. Ponticelli C. Cyclosporine: from renal transplantation to autoimmune diseases. Ann NY Acad Sci 2005; 1051: 551–558. 3. Borel JF, Feurer C, Magnée C, Stähelin H. Effect of the new-anti- lymphocytic peptide cyclosporin A in animals. Immunology 1977; 32: 1017–1025.
  2. Wartburg A, Traber R. Chemistry of the natural cyclosporin metabolites. Prog Allergy 1986; 38: 28–45. Van Buren CT. Cyclosporine: progress, problems and perspectives. Surg Clin N Am 1986; 66: 435–449.
  3. Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Graddock GN, Pentlow BD, Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323–1327.
  4. Bennett WM, Porter GA. Cyclosporine-associated hypertension. Am J Med 1988; 85: 131–133.
  5. Diepering H, Frandsen NE, Kemp E. Cyclosporin A: bright prospects for organ transplantation? Ugeskr Laeger 1983; 145: 2749–2752.
  6. Rezzani R, Rodella L, Bianchi R. Melatonin antagonises the cyclosporine A immunosuppressive effects in rat thymuses. Int Immunopharmacol 2001; 1: 1615–1619. Rezzani R. Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies. Histol Histopathol 2006; 21: 301–316.
  7. Kurus M, Esrefoglu M, Karabulut AB, Sogutlu B, Kaya M, Otlu A. Oral L-arginine protects against cyclosporine-induced hepatotoxicity in rats. Exp Toxicol Pathol 2008; 60: 411–419.
  8. Dechant K, Noble S. Erdosteine. Drugs 1996; 52: 875–881.
  9. Braga P, Dal Sasso M, Zuccotti T. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneimittelforschung 2000; 50: 739–746.
  10. Koc A, Duru M, Ciralik H, Akcan R, Sogut S. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats. Mol Cell Biochem 2005; 278: 79–84.
  11. Yagmurca M, Bas O, Mollaoglu H, Sahin O, Nacar A, Karaman O, Songur A. Protective effects of erdosteine on doxorubicin- induced hepatotoxicity in rats. Arch Med Res 2007; 38: 380– 385. Kurus M, Esrefoglu M, Sogutlu G, Atasever A. Melatonin prevents cyclosporine-induced hepatotoxicity in rats. Med Princ Pract 2009; 18: 407–410.
  12. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497–500.
  13. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: